PortfoliosLab logoPortfoliosLab logo
ISIN
US2074101013
CUSIP
207410101
IPO Date
Jul 23, 1987

Highlights

Market Cap
$996.41M
Enterprise Value
$996.41M
EPS (TTM)
$1.77
PE Ratio
18.36
PEG Ratio
0.13
Total Revenue (TTM)
$1.37B
Gross Profit (TTM)
$756.17M
EBITDA (TTM)
$188.54M
Year Range
$31.44 - $56.64
Target Price
$78.00

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


CONMED Corporation

Often compared with CNMD:
CNMD vs. QSIAWCNMD vs. SPY

Performance

CNMD Performance Chart

CONMED Corporation (CNMD) is down 19.9% since the beginning of the year. At $33 per share, CNMD is trading 42.5% below its 52-week high of $57. Investors who bought $1,000 worth of CNMD shares 5 years ago would now be looking at an investment worth $238.


Loading charts...

S&P 500 Index

Returns By Period

CONMED Corporation (CNMD) has returned -19.85% so far this year and -37.41% over the past 12 months. Over the last ten years, CNMD has returned -2.05% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.


CONMED Corporation

1D
-0.12%
1M
-12.60%
YTD
-19.85%
6M
-18.73%
1Y
-37.41%
3Y*
-36.77%
5Y*
-24.93%
10Y*
-2.05%

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CNMD Monthly Returns History

Based on dividend-adjusted daily data since Mar 26, 1990, CNMD's average daily return is +0.08%, while the average monthly return is +1.48%. At this rate, an investment would double in approximately 3.9 years.

Historically, 56% of months were positive and 44% were negative. The best month was Nov 1990 with a return of +60.0%, while the worst month was Jul 2000 at -48.3%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 6 months.

On a daily basis, CNMD closed higher 48% of trading days. The best single day was Mar 24, 2020 with a return of +21.8%, while the worst single day was Oct 9, 1992 at -47.9%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-5.44%19.82%-23.13%3.68%-2.62%-8.85%-19.85%
20254.88%-17.57%2.41%-18.68%15.56%-7.89%-1.79%6.28%-13.16%-6.44%-1.32%-6.49%-40.03%
2024-12.70%-15.98%-0.07%-15.11%12.44%-9.06%-0.40%6.05%-1.51%-5.12%8.50%-7.30%-36.84%
20238.03%0.45%8.21%20.90%-3.40%12.20%-10.92%-7.92%-9.35%-3.36%10.07%2.27%24.45%
2022-2.95%6.24%1.78%-10.49%-12.54%-17.48%1.95%-9.28%-9.29%-0.55%3.91%7.22%-36.98%
2021-0.09%9.97%6.29%7.93%-2.31%-0.04%0.37%-4.78%-0.23%11.81%-10.13%7.99%27.35%

Benchmark Metrics

CONMED Corporation has an annualized alpha of 12.72%, beta of 0.86, and R2 of 0.11 versus S&P 500 Index. Calculated based on daily prices since March 26, 1990.

  • This stock captured 109.60% of S&P 500 Index gains and 103.21% of its losses - amplifying both gains and losses, but participating more in upside than downside.
  • R2 of 0.11 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
12.72%
Beta
0.86
0.11
Upside Capture
109.60%
Downside Capture
103.21%

Return for Risk

Risk / Return Rank

CNMD ranks 7 for risk / return — in the bottom 7% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


CNMD Risk / Return Rank: 77
Overall Rank
CNMD Sharpe Ratio Rank: 66
Sharpe Ratio Rank
CNMD Sortino Ratio Rank: 88
Sortino Ratio Rank
CNMD Omega Ratio Rank: 1010
Omega Ratio Rank
CNMD Calmar Ratio Rank: 77
Calmar Ratio Rank
CNMD Martin Ratio Rank: 55
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for CONMED Corporation (CNMD) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CNMDBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-2.96

Sortino ratioReturn per unit of downside risk

-4.03

Omega ratioGain probability vs. loss probability

0.85

1.37

-0.51

Calmar ratioReturn relative to maximum drawdown

-0.89

2.78

-3.67

Martin ratioReturn relative to average drawdown

-1.53

12.44

-13.97

Dividends

Dividend History

CONMED Corporation provided a 0.61% dividend yield over the last twelve months, with an annual payout of $0.20 per share.


0.60%0.80%1.00%1.20%1.40%1.60%1.80%$0.00$0.20$0.40$0.60$0.8020152016201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021202020192018201720162015
Dividend$0.20$0.60$0.80$0.80$0.80$0.80$0.80$0.80$0.80$0.80$0.80$0.80

Dividend yield

0.61%1.48%1.17%0.73%0.90%0.56%0.71%0.72%1.25%1.57%1.81%1.82%

Monthly Dividends

The table displays the monthly dividend distributions for CONMED Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2025$0.00$0.00$0.20$0.00$0.00$0.20$0.00$0.00$0.20$0.00$0.00$0.00$0.60
2024$0.00$0.00$0.20$0.00$0.00$0.20$0.00$0.00$0.20$0.00$0.00$0.20$0.80
2023$0.00$0.00$0.20$0.00$0.00$0.20$0.00$0.00$0.20$0.00$0.00$0.20$0.80
2022$0.00$0.00$0.20$0.00$0.00$0.20$0.00$0.00$0.20$0.00$0.00$0.20$0.80
2021$0.00$0.00$0.20$0.00$0.00$0.20$0.00$0.00$0.20$0.00$0.00$0.20$0.80

Dividend Yield & Payout


Dividend Yield

CONMED Corporation has a dividend yield of 0.61%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.

Payout Ratio

CONMED Corporation has a payout ratio of 33.85%, which is quite average when compared to the overall market. This suggests that CONMED Corporation strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the CONMED Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the CONMED Corporation was 78.76%, occurring on Jun 17, 2026. The portfolio has not yet recovered.

The current CONMED Corporation drawdown is 78.47%.


Related event

Drawdown

Fall

Recovery

Underwater

2026 bear market2026
-78.76%Jun 2026
4y 7mo
4y 7moNov 2021 - now
1992 bear market1992
-76.46%Oct 1992
7mo 29d2y 9mo
3y 5moFeb 1992 - Jul 1995
COVID crash2020
-65.68%Mar 2020
3mo 28d9mo 19d
1y 1moNov 2019 - Jan 2021
Financial crisis2007–2009
-64.60%Mar 2009
5mo 18d4y 6d
4y 5moSep 2008 - Mar 2013
Dot-com crash2000–2002
-64.58%Aug 2000
1y 2mo1y 6mo
2y 9moJun 1999 - Mar 2002

Drawdown Indicators


CNMDBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-78.76%

-56.78%

-21.98%

Max Drawdown (1Y)

Largest decline over 1 year

-42.25%

-9.10%

-33.15%

Max Drawdown (3Y)

Largest decline over 3 years

-75.85%

-18.90%

-56.95%

Max Drawdown (5Y)

Largest decline over 5 years

-78.76%

-25.43%

-53.33%

Max Drawdown (10Y)

Largest decline over 10 years

-78.76%

-33.92%

-44.84%

Current Drawdown

Current decline from peak

-78.47%

-1.80%

-76.67%

Average Drawdown

Average peak-to-trough decline

-26.43%

-10.71%

-15.72%

Ulcer Index

Depth and duration of drawdowns from previous peaks

24.41%

2.03%

+22.38%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of CONMED Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how CONMED Corporation is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for CNMD, comparing it with other companies in the Medical Devices industry. Currently, CNMD has a P/E ratio of 18.4. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for CNMD compared to other companies in the Medical Devices industry. CNMD currently has a PEG ratio of 0.1. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for CNMD relative to other companies in the Medical Devices industry. Currently, CNMD has a P/S ratio of 0.7. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with CNMD

Add CONMED Corporation to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with CNMD